A Geneva BCI Company Records Its First Human Neural Data, and Europe Gets a Serious Entrant
- ABILITY Neurotech completed the first-in-human procedure for its brain-computer interface at the Department of Neurosurgery, TUM University Hospital Rechts der Isar in Munich.
- The study will involve up to five patients undergoing brain tumour surgery, capturing 20 to 30 minutes of intraoperative neural recording each. Initial patients were recorded under general anaesthetic.
- Next stages target neural decoding in conscious patients performing speech and motor tasks. A long-term implantation study follows.
- ABILITY is a Wyss Center spinout building a fully implantable optical BCI for ALS, spinal cord injury and stroke, on a declared dual EU/US regulatory pathway.
CI read
Keep the stage honest: this is signal-acquisition validation during tumour surgery, not a chronic implant, and it is the first of several steps before anything is restored for anyone. What makes it worth logging is geography and sequencing. Brain-computer interfaces have been an American story told largely by well-funded private companies; a Wyss Center spinout validating in one of Europe’s leading neurosurgery departments, on an explicit dual EU/US path, is the field acquiring a second centre of gravity. The same Munich department performed Europe’s first microelectrode sensorimotor BCI implant in summer 2025. Read alongside the interhuman brain link published last week, that is a category compounding rather than idling.